SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 72 filers reported holding SERES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,020 | -50.1% | 21,017 | +0.4% | 0.00% | – |
| Q2 2023 | $100,241 | +4.4% | 20,927 | +23.6% | 0.00% | – |
| Q1 2023 | $95,993 | -11.5% | 16,930 | -12.6% | 0.00% | – |
| Q4 2022 | $108,478 | -7.3% | 19,371 | +6.4% | 0.00% | – |
| Q3 2022 | $117,000 | +125.0% | 18,204 | +20.6% | 0.00% | – |
| Q2 2022 | $52,000 | -67.7% | 15,097 | -33.1% | 0.00% | – |
| Q1 2022 | $161,000 | -31.2% | 22,556 | -19.7% | 0.00% | – |
| Q4 2021 | $234,000 | +18.2% | 28,103 | -1.4% | 0.00% | -100.0% |
| Q3 2021 | $198,000 | -76.0% | 28,511 | -17.4% | 0.00% | -50.0% |
| Q2 2021 | $824,000 | +46.1% | 34,529 | +26.1% | 0.00% | 0.0% |
| Q1 2021 | $564,000 | -12.6% | 27,386 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $645,000 | +9.0% | 26,322 | +25.9% | 0.00% | -33.3% |
| Q3 2020 | $592,000 | +604.8% | 20,899 | +18.9% | 0.00% | – |
| Q2 2020 | $84,000 | +100.0% | 17,573 | +49.2% | 0.00% | – |
| Q1 2020 | $42,000 | -39.1% | 11,777 | -41.4% | 0.00% | – |
| Q4 2019 | $69,000 | -25.8% | 20,085 | -13.0% | 0.00% | -100.0% |
| Q3 2019 | $93,000 | +102.2% | 23,084 | +62.8% | 0.00% | – |
| Q2 2019 | $46,000 | -58.6% | 14,176 | -12.0% | 0.00% | -100.0% |
| Q1 2019 | $111,000 | +54.2% | 16,116 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | -50.3% | 16,019 | -16.4% | 0.00% | 0.0% |
| Q3 2018 | $145,000 | -14.7% | 19,157 | -3.2% | 0.00% | 0.0% |
| Q2 2018 | $170,000 | +8.3% | 19,798 | -7.3% | 0.00% | 0.0% |
| Q1 2018 | $157,000 | -37.7% | 21,353 | -14.2% | 0.00% | -50.0% |
| Q4 2017 | $252,000 | -35.2% | 24,873 | +2.7% | 0.00% | -50.0% |
| Q3 2017 | $389,000 | +52.5% | 24,222 | +7.5% | 0.00% | +33.3% |
| Q2 2017 | $255,000 | -4.1% | 22,541 | -4.5% | 0.00% | 0.0% |
| Q1 2017 | $266,000 | -8.9% | 23,591 | -20.1% | 0.00% | 0.0% |
| Q4 2016 | $292,000 | -12.3% | 29,524 | +8.8% | 0.00% | -40.0% |
| Q3 2016 | $333,000 | -63.7% | 27,126 | -14.2% | 0.01% | -58.3% |
| Q2 2016 | $918,000 | +15.3% | 31,599 | +5.5% | 0.01% | +9.1% |
| Q1 2016 | $796,000 | -30.5% | 29,959 | -8.3% | 0.01% | -21.4% |
| Q4 2015 | $1,146,000 | – | 32,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |